|
Monday, March 3 — 8:00 AM — CC Korbel BR 1
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - BREAST PATHOLOGY
Chaired by: Sunil Badve and Laura Collins
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Lobular Involution: A Quantitative Trait Directly Linked to Breast Cancer
(199)
KP McKian, CA Reynolds, RA Vierkant, S Anderson, MH Frost, DW Visscher, A Nassar, LC Hartmann - Mayo Clinic, Rochester; University of Michigan, Ann Arbor
|  Add |
| 8:15 |
Expression of Fatty Acid Synthase in Columnar Cell Lesions of the Breast
(251)
GA Turashvili, PH Watson, CB Gilks, DF Schaeffer, KC Jensen, KD Montgomery, JM van de Rijn, SA Aparicio - BC Cancer Research Centre, BC Cancer Agency and University of British Columbia, Vancouver, BC, Canada; Stanford University Medical Center, Stanford, CA
| Add |
| 8:30 |
Histologic Associations and Long-Term Cancer Risk in Columnar Cell Lesions of the Breast: A Retrospective Cohort and Nested Case-Control Study
(98)
FI Boulos, WD Dupont, JF Simpson, PA Schuyler, ME Sanders, DL Page - Vanderbilt University Medical Center, Nashville, TN
| Add |
| 8:45 |
Monomorphic Epithelial Proliferation Lesions Associated with Ipsilateral Breast Failure Carcinomas Following Breast Conserving Therapy and Radiation Therapy: Evidence That MEPs Are the Background Pool of Precursor Lesions from Which Carcinomas Arise and Are a Key IBF Risk-Reduction Lesion Eradicated by RT
(137)
NS Goldstein, FA Vicini - William Beaumont Hospital, Royal Oak, MI
| Add |
| 9:00 |
Clinicopathologic Features of DCIS in Women under Age of 35
(128)
J Gao, A Mangat, S Khan, C Schiller, B Susnik - Northwestern University, Chicago, IL
| Add |
| 9:15 |
Beta-Catenin Is Activated in Residual Breast Carcinoma after Neo-Adjuvant Chemotherapy
(180)
LP Kunju, M Banerjee, M Hayes, CG Kleer - University of Michigan, Ann Arbor, MI
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Improving Interobserver Reproducibility of Nodal Stage Classification through Standardized Histologic Criteria and Image-Based Training
(252)
RR Turner, DL Weaver, G Cserni, SC Lester, K Hirsch, DA Elashoff, PL Fitzgibbons, G Viale, G Mazzarol, JA Ibarra, SJ Schnitt, AE Giuliano - John Wayne Cancer Institute, Santa Monica, CA; University of Vermont, Burlington, VT; Bacs-Kiskun County Hospital, Kecskemet, Hungary; Brigham and Women's Hospital, Boston, MA; UCLA School of Medicine, Los Angeles, CA; Saint Jude Medical Center, Fullerton, CA; European Institute of Oncology and University of Milan, Milan, Italy; Orange Coast Memorial, Fountain Valley, CA; Beth Isreal Deaconess, Boston, MA
| Add |
| 11:15 |
Analysis of Revised Nottingham Tumor Grade Constitutive Components and Recurrence Free Interval in ECOG Breast Cancer Study E2197
(82)
FL Baehner, LJ Goldstein, R Gray, T Maddala, S Shak, GW Sledge, JA Sparano, S Badve - UCSF, SF, CA; Genomic Health, RC, CA; Eastern Cooperative Oncology Group, Brookline, MA
| Add |
| 11:30 |
Androgen Receptor Expression in Breast Carcinomas Arising in BRCA1 and BRCA2 Mutation Carriers
(207)
AM O'Shea, AM Mulligan, AL Bane, D Pinnaduwage, IL Andrulis, FP O'Malley - Mount Sinai Hospital, Toronto, ON, Canada
| Add |
| 11:45 |
BRCA1-Associated Ductal Carcinoma In Situ of the Breast Frequently Shows a Basal-Like Phenotype
(189)
CA Livasy, CM Perou - University of North Carolina, Chapel Hill, NC
| Add |
|
|
